Statistics for Patient-Reported Outcomes from a Randomized, Active-Controlled, Open-Label, Phase 3 Trial of Burosumab Versus Conventional Therapy in Children with X-Linked Hypophosphatemia
Total visits
views | |
---|---|
Patient-Reported Outcomes from a Randomized, Active-Controlled, Open-Label, Phase 3 Trial of Burosumab Versus Conventional Therapy in Children with X-Linked Hypophosphatemia | 67 |
Total visits per month
views | |
---|---|
January 2024 | 0 |
February 2024 | 0 |
March 2024 | 0 |
April 2024 | 0 |
May 2024 | 0 |
June 2024 | 0 |
July 2024 | 0 |
File Visits
views | |
---|---|
223_2020_Article_797.pdf | 27 |
Top country views
views | |
---|---|
United States | 55 |
France | 1 |
South Korea | 1 |
Malaysia | 1 |
Top city views
views | |
---|---|
Wilmington | 37 |
Fairfield | 9 |
Ann Arbor | 1 |
Baltimore | 1 |
Bartlesville | 1 |
Bloomington | 1 |
Cambridge | 1 |
Houston | 1 |
Nanterre | 1 |
Seremban | 1 |